Hymenoptera anaphylaxis is responsible for 50 deaths annually. This may be an underestimation because not all anaphylactic episodes are recognized or reported. Unexplained deaths at the poolside or on golf courses, as well as those attributed to cardiac causes, may be caused by unrecognized anaphylaxis. Venom immunotherapy (VIT) is highly effective in reducing an individual's risk of anaphylaxis. This review will discuss the diagnosis and treatment of hymenoptera sensitivity, patient selection for IT, standard VIT, and modified allergens.
Document Type: Conference Report
Publication date: November 1, 2002
More about this publication?
Allergy and Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists.
The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma.
Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.
Articles marked "F" offer free full text for personal noncommercial use only.